Ribosomal resistance of clinical enterococcal to streptomycin isolates
- 1 March 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 25 (3), 398-399
- https://doi.org/10.1128/aac.25.3.398
Abstract
The mechanism of high-level resistance to streptomycin was studied in 12 clinical isolates of Streptococcus faecalis. Six strains produced streptomycin-modifying enzymes. Each of three enzyme-negative strains tested demonstrated ribosomal resistance to streptomycin. Lack of ribosomal susceptibility is a significant cause of high-level streptomycin resistance among clinical enterococcal isolates.Keywords
This publication has 11 references indexed in Scilit:
- Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococciAntimicrobial Agents and Chemotherapy, 1983
- Enterococci from Bangkok, Thailand, with high-level resistance to currently available aminoglycosidesAntimicrobial Agents and Chemotherapy, 1983
- High-Level Resistance to Gentamicin in Clinical Isolates of EnterococciThe Journal of Infectious Diseases, 1983
- Aminoglycoside uptake and mode of action—with special reference to streptomycin and gentamicinJournal of Antimicrobial Chemotherapy, 1981
- Aminoglycoside-Inactivating Enzymes in Clinical Isolates of Streptococcus FaecalisJCI Insight, 1978
- Resistance to Six Aminoglycosidic Aminocyclitol Antibiotics Among Enterococci: Prevalence, Evolution, and Relationship to Synergism with PenicillinAntimicrobial Agents and Chemotherapy, 1977
- Mechanisms of Antibiotic Resistance in BacteriaAnnual Review of Biochemistry, 1973
- Evidence for Mutation to Streptomycin Resistance in Clinical Strains of Staphylococcus aureusJournal of General Microbiology, 1972
- Mechanisms and Spectrum of Streptomycin Resistance in a Natural Population of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1972
- Recognition of group D streptococcal species of human origin by biochemical and physiological tests.1972